Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib/II open-label, randomized evaluation of 2L atezolizumab (atezo) + BL-8040 versus control in MORPHEUS-pancreatic ductal adenocarcinoma (M-PDAC) and MORPHEUS-gastric cancer (M-GC)
    Meeting Abstract

    Oh, D. Y.; Ajani, J. A.; Bang, Y. J.; Chung, H. C.; Lacy, J.; Lee, J.; Macarulla, T.; Manji, G. A.; O'Reilly, E. M.; Allen, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pancreatic ductal adenocarcinoma (PDAC), BRCA: Detailed analysis and outcomes of cohort from Memorial Sloan Kettering Cancer Center (MSK)
    Meeting Abstract

    Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Li, J.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of prior irinotecan exposure on outcomes of metastatic pancreatic cancer (mPC) patients
    Meeting Abstract

    O'Reilly, E. M.; Surinach, A.; Dillon, A.; Cockrum, P.; Yu, K. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Real-world patterns of care among patients with metastatic pancreatic cancer (mPC)
    Meeting Abstract

    O'Reilly, E. M.; Surinach, A.; Wu, Z.; Cockrum, P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A randomized, multicenter, phase II trial of gemcitabine (G), cisplatin (C) plus /- veliparib (V) in patients with pancreas adenocarcinoma (PDAC) and a known germline (g)BRCA/ PALB2 mutation
    Meeting Abstract

    O'Reilly, E. M.; Lee, J. W.; Zalupski, M.; Capanu, M.; Park, J.; Golan, T.; Tahover, E.; Lowery, M. A.; Chou, J. F.; Sahai, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Early progression (progr) in patients (pts) with metastatic pancreatic cancer (mPaC) and a germline BRCA mutation (gBRCAm): Phase III POLO trial of olaparib (O) versus placebo (P)
    Meeting Abstract

    Macarulla, T.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pancreatic cancer (PaC)-specific health-related quality of life (HRQoL) with maintenance olaparib (O) in patients (pts) with metastatic (m) PaC and a germline BRCA mutation (gBRCAm): Phase III POLO trial
    Meeting Abstract

    Hall, M. J.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I study to evaluate the safety and tolerability of AB680 combination therapy in participants with gastrointestinal malignancies
    Meeting Abstract

    Bendell, J. C.; Manji, G. A.; Pant, S.; Lai, D. W.; Colabella, J.; Berry, W.; Paoloni, M. C.; Grossman, W. J.; O'Reilly, E. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA/PALB2 mutation
    Journal Article

    O'Reilly, E. M.; Lee, J. W.; Zalupski, M.; Capanu, M.; Park, J.; Golan, T.; Tahover, E.; Lowery, M. A.; Chou, J. F.; Sahai, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The evolutionary origins of recurrent pancreatic cancer
    Journal Article

    Sakamoto, H.; Attiyeh, M. A.; Gerold, J. M.; Makohon-Moore, A. P.; Hayashi, A.; Hong, J.; Kappagantula, R.; Zhang, L.; Melchor, J. P.; Reiter, J. G.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save